Activation of ventral tegmental GABAB receptors inhibits morphine-induced place preference in rats

Eur J Pharmacol. 1996 Oct 17;313(3):169-73. doi: 10.1016/0014-2999(96)00642-5.

Abstract

The effect of microinjection of a GABAB receptor agonist, baclofen, into the ventral tegmental area on the rewarding effect of morphine was investigated using the conditioned place preference paradigm in rats. Morphine (1-8 mg/kg, s.c.) caused a dose-related place preference for the drug-associated place. In contrast, microinjection of baclofen (0.1-1 nmol/side) into the ventral tegmental area did not produce a significant preference for either compartment of the test box. Pretreatment with baclofen (0.1-1 nmol/side) into the ventral tegmental area dose dependently suppressed the morphine (8 mg/kg, s.c)-induced place preference. This suppression of the morphine (8 mg/kg, s.c.)-induced place preference by baclofen (1 nmol/side), but not with the GABAA receptor antagonist bicuculline (1 nmol/side). The present results suggest that a decrease in GABAB neurotransmission in the ventral tegmental area, which may be produced via inhibition of a tonic GABAergic input by morphine, may be involved in the expression of the rewarding effect of morphine.

MeSH terms

  • Animals
  • Baclofen / pharmacology
  • Behavior, Animal / drug effects*
  • Dose-Response Relationship, Drug
  • GABA Agonists / pharmacology
  • GABA-B Receptor Agonists*
  • Male
  • Microinjections
  • Morphine / antagonists & inhibitors*
  • Morphine / pharmacology*
  • Narcotic Antagonists / pharmacology*
  • Narcotics / pharmacology*
  • Rats
  • Rats, Sprague-Dawley
  • Ventral Tegmental Area / physiology*
  • Ventral Tegmental Area / ultrastructure*

Substances

  • GABA Agonists
  • GABA-B Receptor Agonists
  • Narcotic Antagonists
  • Narcotics
  • Morphine
  • Baclofen